Royal Bank of Canada reissued their sector perform rating on shares of Colgate-Palmolive (NYSE:CL – Free Report) in a research note published on Wednesday,Benzinga reports. Royal Bank of Canada currently has a $101.00 price target on the stock.
A number of other analysts have also recently weighed in on CL. UBS Group decreased their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $102.00.
View Our Latest Stock Report on CL
Colgate-Palmolive Stock Down 0.2 %
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.
Insider Transactions at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.34% of the company’s stock.
Institutional Trading of Colgate-Palmolive
Hedge funds and other institutional investors have recently made changes to their positions in the stock. D Orazio & Associates Inc. boosted its position in shares of Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the period. Fiducient Advisors LLC boosted its position in Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after purchasing an additional 110 shares during the period. Sequoia Financial Advisors LLC lifted its stake in shares of Colgate-Palmolive by 0.6% in the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after buying an additional 113 shares during the last quarter. Great Waters Wealth Management lifted its holdings in shares of Colgate-Palmolive by 1.5% during the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock worth $796,000 after buying an additional 117 shares during the last quarter. Finally, Waldron Private Wealth LLC boosted its holdings in Colgate-Palmolive by 2.1% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after purchasing an additional 118 shares during the period. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- The 3 Best Blue-Chip Stocks to Buy Now
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- Canadian Penny Stocks: Can They Make You Rich?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Investing in Travel Stocks Benefits
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.